论文部分内容阅读
目的:观察和分析对COPD患者采取β2受体激动剂和抗胆碱能药物治疗的临床疗效及价值。方法:选取在我院呼吸科接受治疗的COPD患者118例为研究对象,采取数字标记法将上述选取对象分成对照组和观察组,观察和分析两组患者肺部功能的改善情况和治疗有效率。结果:观察组59例患者治疗总有效率明显高于对照组,对比差异有统计学意义(P<0.05);观察组患者FEV1、FVC以及FEV1/FVC等肺部功能指标改善情况均明显优于对照组,上述对比均具有显著性差异(P<0.05)。结论:对于COPD患者给予β2受体激动剂联合抗胆碱能药物进行治疗,疗效明确,对改善患者肺部功能,减轻临床症状,改善预后及生活质量有着积极的意义,值得在临床上推广。
OBJECTIVE: To observe and analyze the clinical efficacy and value of β2-agonist and anticholinergic drugs in patients with COPD. Methods: A total of 118 patients with COPD who were treated in our department of respiratory department were enrolled in this study. The subjects were divided into control group and observation group by digital signature method. The improvement of lung function and treatment efficiency were observed and analyzed . Results: The total effective rate of 59 patients in the observation group was significantly higher than that in the control group (P <0.05). The improvement of pulmonary function indexes such as FEV1, FVC and FEV1 / FVC in the observation group were significantly better than those in the control group The control group, the above comparison had significant difference (P <0.05). CONCLUSIONS: The treatment of patients with COPD with β2-agonist combined with anticholinergic drugs has a definite curative effect and has positive significance for improving lung function, alleviating clinical symptoms, improving prognosis and quality of life in patients with COPD, and is worthy of clinical promotion.